Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-29 @ 1:46 PM
Study NCT ID:
NCT05094804
Status:
UNKNOWN
Last Update Posted:
2023-11-02
First Post:
2021-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Sponsor:
OncoResponse, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-27
First Submit QC Date:
None
Study First Post Date:
2021-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-31
Last Update Post Date:
2023-11-02
Last Update Post Date Type:
ACTUAL